trial seenhigh2026-10-19
null → {"status":"RECRUITING","last_update_posted_at":"2026-10-19"}
📡 TrialPulse
Global clinical trial visibility
RECRUITINGPHASE1
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Registry history
Events detected for this trial — severity × confidence × recency
How to read the confidence score: 1.0 = observed — the registry record itself changed (a fact). <1.0 (e.g. 0.7) = signal — inferred by a heuristic rule from the data; it flags something worth a look, it is not a confirmed finding. Values below are shown raw from the database; the highlighted parts are the actual values, dimmed parts are JSON syntax.
Key dates
Start2023-12-18
Primary completion2027-06-30
Enrollment65estimated
Recurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid AdenocarcinomaRecurrent Endometrial Low Grade Endometrioid AdenocarcinomaRecurrent Ovarian Clear Cell AdenocarcinomaRecurrent Ovarian Endometrioid AdenocarcinomaDRUGPROCEDURE
Site map
Per-site markers colored by site status
recruitingUniversity of New Mexico Cancer CenterAlbuquerque, United States
recruitingAugusta University Medical CenterAugusta, United States
recruitingUniversity of Chicago Comprehensive Cancer CenterChicago, United States
active not recruitingCase Western Reserve UniversityCleveland, United States
recruitingCleveland Clinic FoundationCleveland, United States
recruitingOhio State University Comprehensive Cancer CenterColumbus, United States
recruitingWayne State University/Karmanos Cancer InstituteDetroit, United States
recruitingUniversity of Iowa/Holden Comprehensive Cancer CenterIowa City, United States
recruitingMedical College of WisconsinMilwaukee, United States
recruitingUniversity of Oklahoma Health Sciences CenterOklahoma City, United States
recruitingNRG OncologyPhiladelphia, United States
recruitingThomas Jefferson University HospitalPhiladelphia, United States
recruitingUniversity of Pennsylvania/Abramson Cancer CenterPhiladelphia, United States
recruitingWomen and Infants HospitalProvidence, United States